Efficacy of mFOLFOX6 with bebacizumab or cetuximab based on K-ras status for unresectable hepatic metastasis of colorectal cancer
Phase 2
- Conditions
- nresectable hepatic metastasis of colorectal cancer
- Registration Number
- JPRN-UMIN000004310
- Lead Sponsor
- Kyoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Not provided
Exclusion Criteria
1. Brain metastasis, brain tumor 2. symptomatic cerebrovascular disease 3. active bleeding 4. uncontrolled hypertention etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The ratio of R0 resection or clinical CR
- Secondary Outcome Measures
Name Time Method Safety, The ratio of R0 hepatic resection, overall response rate, pathological response rate, progression free survival, 2-year survival rate, Compliance of initial regimen, relative dose intensity